Q1 2023 Renalytix PLC Earnings Call Transcript
Good morning. Welcome to the Renalytix conference call to review first-quarter fiscal 2023 financial results. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners for a few introductory comments.
Thank you, Charie. Thank you all for participating in today's call. Joining me today from Renalytix are James McCullough, Chief Executive Officer; and James Sterling, Chief Financial Officer, to provide formal remarks; and Tom McLain, President; and Fergus Fleming, Chief Technology Officer, are also on hand for the Q&A session.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events, results or performance are forward looking statements.
Examples of these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |